How has been the historical performance of Medico Remedies?
Medico Remedies has shown consistent growth in net sales and profitability, with net sales increasing from 97.69 Cr in Mar'19 to 150.94 Cr in Mar'25, and profit after tax rising from 1.57 Cr to 10.09 Cr during the same period, reflecting improved operational efficiency and a growing profitability margin. Total assets also expanded significantly, indicating a robust financial trajectory.
Answer:The historical performance of Medico Remedies shows a consistent growth trend in net sales and profitability over the years.Breakdown:
Medico Remedies has demonstrated a steady increase in net sales, rising from 97.69 Cr in Mar'19 to 150.94 Cr in Mar'25. This growth is accompanied by a rise in total operating income, which reached 150.94 Cr in Mar'25, up from 144.92 Cr in Mar'24. The company's operating profit (PBDIT) has also improved significantly, climbing to 17.69 Cr in Mar'25 from 4.66 Cr in Mar'19, indicating enhanced operational efficiency. Profit before tax has followed a similar upward trajectory, reaching 13.50 Cr in Mar'25 compared to just 2.18 Cr in Mar'19. Consequently, profit after tax has increased to 10.09 Cr in Mar'25 from 1.57 Cr in Mar'19, reflecting a growing profitability margin, which stands at 6.68% in Mar'25. On the balance sheet, total assets have expanded to 119.55 Cr in Mar'25 from 75.27 Cr in Mar'20, while total liabilities have also increased to 119.55 Cr, with a notable rise in short-term borrowings. The company's cash flow from operating activities has shown fluctuations, with a positive cash flow of 2.00 Cr in Mar'24, contrasting with previous years. Overall, Medico Remedies has shown a robust growth trajectory in both revenue and profitability metrics over the analyzed period.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
